Want to see SE:NNH full AI Analyst Report?
NNH Stock Chart & Stats
kr21.50
kr0.00(0.00%)
At close: 4:00 PM EST
kr21.50
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr11.60 - kr28.00
Previous CloseN/A
Volume5.00K
Average Volume (3M)5.45K
Market Cap
kr75.27M
Enterprise Valuekr111.54M
Total Cash (Recent Filing)kr8.66M
Total Debt (Recent Filing)kr39.66M
Price to Earnings (P/E)28.3
Beta0.30
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.43
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Branded Multi-market DistributionNew Nordic operates a branded product model across retail, pharmacy and distribution partners in multiple international markets. That diversified channel footprint and recognizable brand support durable shelf presence, lower customer-concentration risk and repeatable revenue streams over time.
Manageable Leverage And Stable EquityLeverage around 0.25–0.43 and stable equity indicate a conservative balance sheet that survived prior loss years. Manageable debt affords financial flexibility for working capital and opportunistic investments without large refinancing risk, supporting medium-term operational resilience.
Return To Profitability With Decent Cash ConversionEarnings recovered in 2025 and stayed positive TTM, and free cash flow broadly tracks net income (~0.8–0.9). That alignment suggests the business can convert reported profits into cash, a key durable trait for funding operations and modest distributions when volatility subsides.
Bears Say
Very Thin Operating And Net MarginsTTM net and EBIT margins near low single digits leave little buffer for input-cost inflation, promotional activity or channel margin pressure. Persistently thin margins constrain reinvestment, limit ability to absorb shocks and raise execution risk for sustainable profit growth.
Revenue Growth Has WeakenedA shift from modest growth to slightly negative TTM revenue is a structural concern for scale-dependent businesses. Slower top-line expansion limits margin leverage, reduces bargaining power with retailers and makes it harder to invest in marketing or product development to regain momentum.
Volatile Cash Generation With Sharp FCF DeclineMulti-year swings in operating cash flow and a sharp recent fall in free cash flow increase uncertainty about internal funding capacity. Volatility undermines planning for capex, marketing or dividends and raises reliance on external financing during downturns, limiting strategic optionality.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr11.60 and its highest was kr28.00 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr75.27M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
New Nordic Healthbrands AB’s upcoming earnings report date is Aug 05, 2026 which is in 33 days.
How were New Nordic Healthbrands AB’s earnings last quarter?
New Nordic Healthbrands AB released its earnings results on Apr 29, 2026. The company reported -kr0.462 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.462.
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Annually dividend of kr0.25 which represents an annual dividend yield of N/A. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
New Nordic Healthbrands AB reported an EPS of -kr0.462 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.404%.
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, serum, and other hair care products; and weight loss products. The company sells its products through pharmacies, health stores,beauty stores, and travel retailers, as well as through online stores. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
Technical Analysis
Midsona AB Class B
―
Humble Group AB
―
Skane-moellan AB
―
Cheffelo AB
―
Premium Snacks Nordic AB
―